A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Clinical trial NCT03794440 · UNKNOWN
Trial details
- NCT number
- NCT03794440
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2022-12-01
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.